Amneal Pharmaceuticals, Inc. AMRX Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $127.93M+273% | -$73.88M-51.6% | -$48.72M+80.9% | -$254.79M— | ||
| $31.95M+15.1% | $27.77M+3.5% | $26.82M-15.8% | $31.85M+12.1% | ||
| $339.99M+15.2% | $295.1M-17.3% | $356.92M— | —— | ||
| $70.06M+34.9% | $51.92M+20.1% | $43.22M-6.9% | $46.41M-2.8% | ||
| -$112.26M-78.2% | -$63M+9.0% | -$69.19M+60.3% | -$174.31M+10.2% | ||
| $2.69B— | —— | $217.73M— | $0— | ||
| —— | -$211.79M+0.4% | -$212.57M— | —— | ||
| $194.52M+907% | $19.31M— | —— | -$221.51M— | ||
| $269.93M+11.0% | $243.18M-25.3% | $325.71M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Amneal Pharmaceuticals, Inc. generate?
- Amneal Pharmaceuticals, Inc. (AMRX) generated $305.8M in operating cash flow over the trailing twelve months.
- What is Amneal Pharmaceuticals, Inc.'s free cash flow?
- After $65.1M of capital expenditures, Amneal Pharmaceuticals, Inc.'s free cash flow was $240.8M over the trailing twelve months, down 4.1% year over year.
- Where does Amneal Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Amneal Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
